about
Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth.High-Molecular-Weight Polynucleotides by Transferase-Catalyzed Living Chain-Growth Polycondensation.Photo-Crosslinkable Unnatural Amino Acids Enable Facile Synthesis of Thermoresponsive Nano- to Microgels of Intrinsically Disordered Polypeptides.Recombinant Synthesis of Hybrid Lipid-Peptide Polymer Fusions that Self-Assemble and Encapsulate Hydrophobic Drugs.Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.Injectable tissue integrating networks from recombinant polypeptides with tunable orderAuthor Correction: Injectable tissue integrating networks from recombinant polypeptides with tunable orderGenetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature-triggered hierarchical self-assemblyGenetically Encoded Stealth Nanoparticles of a Zwitterionic Polypeptide-Paclitaxel Conjugate Have a Wider Therapeutic Window than Abraxane in Multiple Tumor ModelsGenomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor modelsVersatile biomanufacturing through stimulus-responsive cell-material feedbackActive Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated DrugGenetically Encoded Cholesterol-Modified PolypeptidesHeuristics for the Optimal Presentation of Bioactive Peptides on Polypeptide MicellesIntrinsically disordered proteins access a range of hysteretic phase separation behaviorsConjugate of Doxorubicin to Albumin-Binding Peptide Outperforms AldoxorubicinIn Pursuit of Zero 2.0: Recent Developments in Nonfouling Polymer Brushes for ImmunoassaysMolecular and Materials Engineering for Delivery of Peptide Drugs to Treat Type 2 DiabetesSediment challenge to promising ultra-low fouling hydrophilic surfaces in the marine environmentQuantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor DensityAvidity and Cell Uptake of Integrin-Targeting Polypeptide Micelles is Strongly Shape-DependentInducible Fibril Formation of Silk-Elastin DiblocksEngineered Ribonucleoprotein Granules Inhibit Translation in ProtocellsArchitectural Modification of Conformal PEG-Bottlebrush Coatings Minimizes Anti-PEG Antigenicity While Preserving Stealth Properties
P50
Q40075759-7475B8E5-34CB-4A19-8E6D-E2B822A239D8Q47213451-3B22F2D5-8C06-4AE0-AEAF-48EDC102E293Q47263102-0784D0A3-0968-47F9-9268-36486E4D2DB8Q47706872-74E62DBB-198F-431B-8112-F88598F43B28Q52649955-4514767A-3379-42C9-9F0C-2EDD3CA976D6Q57464797-313F481D-A625-42CA-9F24-8BE4C53A43E1Q58090242-FD1DD045-55AF-4FC0-8304-811C6E1FBBC1Q88103028-EB77CB75-EC4B-48D4-A6F0-616F27A3CC52Q89996353-4C4F893D-6AF3-4508-866D-53A5F880B3BBQ90089266-2355FAE9-94D3-462C-AD33-69C71D2F921EQ90135142-719E0496-38D7-45CE-BA4A-5B8116874EB4Q90425917-9B527636-43D1-4E3D-B1DB-B66CAC696C2AQ90878619-88C09940-AE26-495E-8B3E-BC0F4803C0CBQ90898198-F9B2281C-C57A-4BC8-9905-FFBCECBBC210Q91017227-6AECCCEE-9AF5-4BF3-9884-3112198CAA2FQ91526511-9CFA9802-37EF-4109-A4AE-99E74ABD5608Q91545805-B5FA639D-7AA0-49D0-8D3B-0907FB6D5224Q91570675-A8E4D698-C330-446A-957E-C184633F1281Q92014832-387D2CA8-C82E-4024-B147-777213B384A0Q92400777-D42C6959-8837-4118-92E1-3FC936F76CC5Q92471874-74A5EA5C-DC98-455E-8FAF-AA8454156A69Q92574102-8C00C0F8-FE15-4A9C-A1BC-27144E15235AQ92594003-66B72903-9FAD-4287-A7B9-982FF0757441Q92601478-D0768057-D58A-45C1-85FD-0BD0EAE53652
P50
description
researcher
@en
wetenschapper
@nl
name
Ashutosh Chilkoti
@en
Ashutosh Chilkoti
@nl
type
label
Ashutosh Chilkoti
@en
Ashutosh Chilkoti
@nl
prefLabel
Ashutosh Chilkoti
@en
Ashutosh Chilkoti
@nl
P31
P496
0000-0002-1569-2228